Skip to main content
. 2022 Mar 25;30(4):567–574. doi: 10.1038/s41417-022-00450-9

Fig. 1. Lenalidomide resistant MM cells have higher SAE2 and global SUMOylation than Lenalidomide sensitive MM cells.

Fig. 1

A Cell viability assay showing Len-sensitive MM1S and Len-resistant MMR10R cell line treated with Lenalidomide at indicated concentrations. IC50 values were calculated by GraphPad Prism 8. B Western blot showing CRBN, IRF4, SAE2, SAE1, UBC9, and global SUMOylation (SUMO-2,3 and SUMO-1) level of MM1S and MMR10R cell lines; GAPDH, loading control. Relative protein level was quantified using Image J, normalized to GAPDH, and labeled below each blotting band.